✦ LIBER ✦

Acute infection of Toxoplasma gondii and cytomegalovirus reactivation in a pediatric patient receiving liver transplant

✍ Scribed by M.L. Galván Ramírez; Y. Castillo-de-León; M. Espinoza-Oliva; M.C. Bojorques-Ramos; L.R. Rodríguez-Pérez; R. Bernal Redondo; I. Cañedo-Solares; L. Espinoza López; D. Correa

Book ID: 110904067
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 718 KB
Volume: 8
Category: Article
ISSN: 1398-2273
DOI: 10.1111/j.1399-3062.2006.00140.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A retrospective study of viral and Toxop

A retrospective study of viral and Toxoplasma gondii infections in 54 liver transplant recipients in Cambridge

✍ Tim Wreghitt; Mark Hughes; Roy Calne 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 870 KB

The value of immunoprophylaxis for cytom

The value of immunoprophylaxis for cytomegalovirus infection with intravenous immunoglobulin in pediatric liver transplant recipients receiving a low-dose immunosupressive regimen

✍ Katrin Krampe; Andrea Briem-Richter; Lutz Fischer; Bjoern Nashan; Rainer Ganscho 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Increased incidence of cytomegalovirus i

Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis

✍ Kevin T. Shiley; Leanne B. Gasink; Todd D. Barton; Patrice Pfeiffenberger; Kim M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Optimal measures for the prevention of cytomegalovirus (CMV) in high-risk orthotopic liver transplant (OLT) patients are unknown. The charts of high-risk OLT recipients with 12 months of follow-up who were transplanted over a 44-month period were reviewed. The incidence of CMV disease in CMV-seropos

Retrospective review of the incidence of

Retrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: Comparison of prophylactic oral ganciclovir and oral valganciclovir

✍ Ashley N. Bedel; Trina S. Hemmelgarn; Rohit Kohli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 747 KB

Cytomegalovirus (CMV) is the most common viral infection after solid organ transplantation (SOT). Safe and effective prophylactic regimens that decrease its incidence after SOT are essential for long-term graft survival. Although valganciclovir is not Food and Drug Administration-approved for CMV pr